• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Polymyalgia rheumatica
 

Polymyalgia rheumatica

on

  • 239 views

 

Statistics

Views

Total Views
239
Views on SlideShare
239
Embed Views
0

Actions

Likes
0
Downloads
2
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Polymyalgia rheumatica Polymyalgia rheumatica Presentation Transcript

    • POLYMYALGIA RHEUMATICA Dr. Arshad Rabbani MBBS,MCPS,FCPS
    • is a clinical syndrome characterized by severe aching and stiffness in the neck, shoulder girdle, and pelvic girdle.
    • Pathophysiology    causes severe pain in the proximal muscle groups; however, no evidence of disease is present at muscle biopsy. Muscle strength and electromyographic findings are normal.  cell-mediated injury to the elastic lamina in the blood vessels in the affected muscle groups.
    • Incidence     Frequency 1 in 200 people aged 50 years or older. Mortality/Morbidity not a life-threatening disease, but it does require treatment for 2-4 years. Race whites >other ethnic groups Sex Females are affected twice as often as males.
    • Symptoms         Pain and stiffness in the proximal muscle groups that usually is symmetrical and worse in the morning. Gel phenomenon (stiffness after prolonged inactivity). Fever (low grade). Weight loss. Fatigue. Depression. No weakness. Abrupt onset of symptoms.
    • Signs    No muscle atrophy. Muscle tenderness. Decreased active range of motion of joints secondary to pain.
    • Lab studies     Erythrocyte sedimentation rate greater than 50 mm/h Normochromic normocytic anemia in 50% of cases Normal creatinine kinase level Negative finding for rheumatoid factor    Mild elevations with liver function test results Mild nonspecific synovitis Negative muscle biopsy findings
    • Treatment  Corticosteroids e.g. prednisone 5-60 mg/d PO qd or divided bid/qid; taper over 2 wk as symptoms resolve.
    • Prognosis    The average length of disease is 3 years. Exacerbations may occur if steroids are tapered too rapidly. Relapse is common.